Vaginitis Overview - Concepedia

Principles

Definition

Vaginitis is an academic concept delineating a specific domain of inquiry focused on the formation and interaction of complex systems, characterized by its emphasis on dynamic processes and emergent properties, and significant for its contribution to theoretical models and analytical frameworks.

Ontological type

Etiology

Treatment Strategies

Clinical Presentation

Key developments

Key Figures

Diagnostic and Etiologic Discovery era

King K. Holmes [1] is a leading figure in the Diagnostic and Etiologic Discovery era [1], with affiliations at Rockefeller University [3] and Harvard University [4]. Holmes contributed to clarifying nongonococcal urethritis etiologies, notably evidence for Chlamydia trachomatis [7] and Ureaplasma urealyticum [7], and helped delineate incidence, etiology, and treatment of the postgonococcal urethritis syndrome [8], advances that were pivotal for reclassifying vaginitis as a multi-etiology clinical entity in this era. Thomas A. Stamey [2] stands as a central figure with affiliations at Stanford University [5] and Johns Hopkins University [6] during this era. Stamey's 1970 paper on Bacteriologic and Hormonal Observations of the Urethra and Vaginal Vestibule in Normal, Premenopausal Women [9] provided baseline data on normal vaginal microbiology and hormonal influences, shaping diagnostic frameworks for vaginal etiologic discovery during the era.

Molecular Diagnostic Standardization era

Sharon L. Hillier [1] is a leading figure in this era of molecular diagnostic standardization, with affiliations at Baylor College of Medicine [3] and the University of Puerto Rico at Carolina [4]. Her key contributions include the paper 'Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation' [5], the article 'Diagnosis and clinical manifestations of bacterial vaginosis' [6], and the work 'Hydrogen Peroxide--Producing Lactobacilli and Acquisition of Vaginal Infections' [7], advances that improved reliability and cross-laboratory comparability in this era. Marijane A. Krohn [2] is another central figure, with research ties to Baylor College of Medicine [3] and the University of Puerto Rico at Carolina [4] during this period. Her contributions include the paper 'Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation' [5] and the paper 'Bacterial vaginosis as a risk factor for post-cesarean endometritis' [8], which together deepened understanding of BV in obstetric contexts and reinforced the move toward standardized diagnostic criteria in this era.

Microbiome Restoration Therapeutics era

Jacques Ravel[1], associated with Johns Hopkins University[3] and the University of Pennsylvania[4] during the Microbiome Restoration Therapeutics era, helped define vaginal microbiome research. His key contributions across Temporal Dynamics of the Human Vaginal Microbiota[6], The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission[7], and the Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy[8] advanced understanding of how microbiota dynamics relate to dysbiosis, HIV risk, and menopausal vaginal health, underscoring the importance of longitudinal profiling for ecosystem-based vaginitis management. Rebecca M. Brotman[2], with affiliations to Johns Hopkins University[3] and the University of Maryland, Baltimore[5], helped propel microbiome-centered vaginitis research during this era. Her contributions through Temporal Dynamics of the Human Vaginal Microbiota[6] and Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy[8] emphasized longitudinal, community-level restoration strategies to reestablish Lactobacillus-dominated states, a cornerstone of durable vaginal health in microbiome restoration therapeutics.